Health Care/Hospital
Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
- 13-week U.S. Phase II study is evaluating the efficacy, safety and tolerability of oral small molecule GLP-1R agonist ASC30, a once-daily tablet, in 100 participants with diabetes. - Topline data from the Phase II study are expected in the third quarter of 2026. HONG KONG, April 27, 2026 /PRN...
2026-04-27 08:10
5157
Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026
- Participants achieving HBsAg loss with pegylated interferon alfa (PEG-IFNα) ± elebsiran or BRII-179 demonstrated favorable off-treatment clinical outcomes, with most HBsAg rebounds <10 IU/mL and HBV DNA rebound infrequent and not associated with clinically significant ALT elevation. These findi...
2026-04-26 19:00
5099
"Strengthening Foundations, Moving Forward Steadily": The 28th National Chinese Life Insurance Congress & 2026 IDA DAY Welcomes Over 2,800 Professionals to Sunway Pyramid Convention Centre, Kuala Lumpur
KUALA LUMPUR, Malaysia, April 25, 2026 /PRNewswire/ -- In an era of persistent global economic turbulence and accelerated industry transformation, the insurance sector is evolving beyond its traditional risk mitigation function toward comprehensive financial planning and long-term value creation....
2026-04-25 07:34
5675
Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
* High Impact Session presented at Heart Rhythm Society's Congress in Chicago * First time showing results of new Less Invasive approach * Improvement in Left Ventricular Ejection Fraction (LVEF), 6 Minute Walk Test (6MWT), Quality of Life (QOL) and New York Heart Association (NYHA) class. C...
2026-04-25 04:00
3746
MALAYSIA HEALTHCARE RETURNS TO MEDAN AS INDONESIAN PATIENTS SEEK TRUSTED SECOND OPINIONS ABROAD
MEDAN, Indonesia, April 25, 2026 /PRNewswire/ -- Malaysia has steadily emerged as one of the most trusted destinations for Indonesian patients seeking timely and reliable care. Following its last major outreach in 2022, Malaysia Healthcare returns to Medan this year, reconnecting with a community...
2026-04-25 02:10
4963
Quasar Medical Celebrates Grand Opening of New Manufacturing Facility in Thailand
The new Chonburi facility increases global manufacturing capacity and strengthens regional supply chain capabilities for leading MedTech customers CHONBURI, Thailand, April 24, 2026 /PRNewswire/ -- Quasar Medical, a global leader in the manufacturing of interventional and minimally invasive medic...
2026-04-24 20:30
2595
From Everyday Wins to Proud Parent Moments: Scott's Children's Day 2026 Goes #AnakSiapaNi
* Launch of #AnakSiapaNi Anak Scott's Lah campaign celebrating proud everyday moments when children stay healthy and active * Scott's and Watsons commit six months of nutritional and essential support to children at House of Love * 24–26 April roadshow at Sunway Velocity Mall featuring inter...
2026-04-24 20:24
2998
Award-Winning XERF™ The Structural Skin Tightening Device, Now Available in Singapore
Cynosure Lutronic's non-invasive facial lifting and tightening device XERF™, recognised at the SBR Technology Excellence Awards 2026 is now offered at aesthetic clinics across Singapore. SINGAPORE, April 23, 2026 /PRNewswire/ -- Patients in Singapore now have access to XERF™, Cynosure Lutronic's...
2026-04-24 13:08
2961
Grand & Straits Optical Highlights Toa Payoh Outlet and Prepares to Introduce Meta Smart Eyewear in Singapore
SINGAPORE, April 24, 2026 /PRNewswire/ -- Grand & Straits Optical, a homegrown optical retailer serving Singapore's heartland communities for more than four decades, is spotlighting its Toa Payoh outlet as part of its ongoing commitment to providing customers with a wide selection of quality eyew...
2026-04-24 12:00
3513
Daewoong Pharmaceutical Hosts 'NABOTA Master Class'… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments
* 74 healthcare professionals from 13 countries attended, recognizing the value of PrabotulinumtoxinA's "Safety" * Comprehensive program including anatomy sessions, proprietary injection techniques, and 1:1 hands-on training * Global participants praise the program as "a platform to share pr...
2026-04-24 11:16
4139
EVERISE NAMED LEADER IN EVEREST GROUP'S HEALTHCARE CUSTOMER EXPERIENCE MANAGEMENT PEAK MATRIX® 2026
PLANTATION, Fla., April 23, 2026 /PRNewswire/ -- Leading global healthcare customer experience provider Everise today announced that it has been named a Leader in Everest Group's Healthcare Customer Experience Management (CXM) Intelligent Operations PEAK Matrix® Assessment 2026 for the first time...
2026-04-23 21:00
2585
Servier completes the acquisition of Day One Biopharmaceuticals
* Acquisition expands Servier's position in oncology with tovorafenib marketed as OJEMDATM in the U.S. in pediatric low-grade glioma. * Transaction also includes a strong oncology pipeline of clinical stage assetsin rare cancers with high unmet needs. * Transaction represents total equity ...
2026-04-23 20:30
3681
Published Clinical Study Illustrates Benefits of Promentum® Recover as Low-Dose Solution for Post Exercise Recovery
MOMENCE, Ill., April 23, 2026 /PRNewswire/ -- A recently published human
clinical study
2026-04-23 20:00
2981
Fosun Health Strengthens Regional Presence at GlobalHealth Asia-Pacific Forum 2026, Showcasing "China Solution" and Winning Three Major Awards
JAKARTA, Indonesia, April 23, 2026 /PRNewswire/ -- Fosun Health made a prominent debut at the GlobalHealth Asia-Pacific Healthcare Insights & Leadership Forum 2026, held alongside the GlobalHealth Asia-Pacific Awards 2026 at the Grand Hyatt Jakarta, joining a distinguished community of healthcare...
2026-04-23 16:46
3591
Mabwell Initiates Phase III Clinical Study of its Nectin-4-Targeting ADC 9MW2821 for the Treatment of Triple-Negative Breast Cancer
SHANGHAI, April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces the initiation of a Phase III clinical study of its proprietary Nectin-4-targeting ADC (R&D code: 9MW2821) for the treatment of triple-ne...
2026-04-23 16:22
4905
2026 ASCO | Mabwell to Present Latest Clinical Data on 9MW2821 Combined with Toripalimab for Urothelial Carcinoma in Oral and Poster Presentations
SHANGHAI, April 23, 2026 /PRNewswire/ -- Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that two latest clinical study results of its Nectin-4-targeting ADC 9MW2821 in combination with toripalimab for urothelial carcinoma wil...
2026-04-23 15:02
1349
2026 ASCO Preview | Alphamab Oncology to Present Clinical Data of TROP2/HER3 Bispecific ADC JSKN016 for HER2-Negative Breast Cancer
SUZHOU, China, April 23, 2026 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) today announced that the results from a Phase I clinical study (JSKN016-101, NCT06592417) of its first-in-class TROP2/HER3 bispecific antibody-drug conjugate (ADC) JSKN016, for the treatment of HER2-negative lo...
2026-04-23 10:19
1176
BioEngine Launches UltraFeed CHO Supplement, Boosting Titers by Up to 48%
SHANGHAI, April 23, 2026 /PRNewswire/ -- Shanghai BioEngine Sci-tech Co., Ltd. announced the launch of UltraFeed, a next-generation fed-batch supplement designed to elevate CHO cell productivity in monoclonal antibody, bispecific, and recombinant protein manufacturing. Across diverse cell lines a...
2026-04-23 09:17
2968
Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform 'IDC224'… Driving Innovation in Subcutaneous (SC) Formulations
SEOUL, South Korea, April 23, 2026 /PRNewswire/ -- Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation subcutaneous (SC) delivery platform designed to simultaneously enhance the administration c...
2026-04-23 06:30
4037
GenScript Leaders Named Entrepreneur Of The Year® 2026 New Jersey Finalists
PISCATAWAY, N.J., April 23, 2026 /PRNewswire/ -- GenScript Biotech Corporation
2026-04-23 04:03
1961
Week's Top Stories
Most Reposted
Digital Identity Co. Modernizes Thailand Immigration Bureau Services with AWS
[Picked up by 314 media titles]
2026-05-28 15:06The Philippines Sets a New Standard in Muslim-Friendly Tourism
[Picked up by 291 media titles]
2026-05-26 10:30
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
[Picked up by 290 media titles]
2026-05-27 09:16
Asian Society of Cardiovascular Imaging and Philips sign MOU to strengthen imaging capabilities across Asia Pacific
[Picked up by 289 media titles]
2026-05-28 17:34
ASEAN Business Advisory Council (ASEAN-BAC) and AVPN Establish Regional Platform to Strengthen Corporate Social Investment and Cross-Sector Collaboration Across Southeast Asia
[Picked up by 288 media titles]
2026-05-28 10:06Most Read
ISDN's IDI Dynamics debuts high-speed laser marker for semiconductor assembly and test (OSAT)
2026-05-26 08:40
6609
Agoda and Philippines Department of Tourism announce strategic partnership to promote and elevate tourism
2026-05-27 09:16
6602
NYSE Content Update: Mastercard Celebrates Two Decades as NYSE-Listed Company
2026-05-26 21:04
6544
/DISREGARD RELEASE: Yangzhou Home Ka Crafts Co., Ltd./
2026-05-29 09:19
6317